- Home
- ROIV vs PLNT Comparison
ROIV vs PLNT Comparison
Compare ROIV & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | PLNT |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 6.3B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ROIV | PLNT |
|---|---|---|
| Price | $27.88 | $72.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | $27.56 | ★ $116.67 |
| AVG Volume (30 Days) | ★ 4.6M | 1.4M |
| Earning Date | 02-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $29,053,000.00 | ★ $1,324,144,000.00 |
| Revenue This Year | N/A | $19.22 |
| Revenue Next Year | $594.84 | $11.66 |
| P/E Ratio | ★ N/A | $38.47 |
| Revenue Growth | N/A | ★ 12.06 |
| 52 Week Low | $8.73 | $72.90 |
| 52 Week High | $30.33 | $114.47 |
Technical Indicators
Market Signals| Indicator | ROIV | PLNT |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 31.08 |
| Support Level | $26.94 | N/A |
| Resistance Level | $27.94 | $76.74 |
| Average True Range (ATR) | 0.90 | 2.47 |
| MACD | -0.20 | 0.38 |
| Stochastic Oscillator | 58.83 | 18.58 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.